Trial Profile
Phase I Clinical Trial with LBH589 and Infusional 5-FU/LV in Patients with Metastatic Colorectal Cancer who Failed 5-FU Based Chemotherapy.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Panobinostat (Primary) ; Fluorouracil; Folinic acid
- Indications Colorectal cancer
- Focus Adverse reactions
- 24 Apr 2014 Status changed from suspended to discontinued as reported by ClinicalTrials.gov record.
- 24 Apr 2014 Status changed from recruiting to suspended as reported by ClinicalTrials.gov record.
- 29 Jan 2014 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.